Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 28, 2011 | March 02, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2011 · Filed March 02, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 109,429 |
Ending reported balance
After 2011-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2011-02-28 · Tax withholding · Disposed 8,526 · Balance 110,993 Row 2 · 2011-02-28 · Sale · Disposed 100 · Balance 110,893 Row 3 · 2011-02-28 · Sale · Disposed 600 · Balance 110,293 Row 4 · 2011-02-28 · Sale · Disposed 864 · Balance 109,429 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 14,342 |
Reported balance
Holding disclosure · report date 2011-02-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 14,342 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2011 Filed Mar 2, 2011 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 864 | $48.02 | $41,491.87 |
DisclosureSEC source: 0001179110-11-003921 · edgar.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,429 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $48.02 | $28,812.60 |
DisclosureSEC source: 0001179110-11-003921 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,293 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $48.02 | $4,802.09 |
DisclosureSEC source: 0001179110-11-003921 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,893 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,526 | $47.64 | $406,178.64 |
DisclosureSEC source: 0001179110-11-003921 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,993 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 36,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003268 · edgar.xml · derivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,800 Underlying: Common shares · 36,800 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,267 on 02/18/2012, 12,266 on 02/18/2013, and 12,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003268 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,519 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,287 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · derivative · entry 8 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,287 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $45.57 | $31,899.00 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,319 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.56 | $4,556.00 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,019 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.56 | $4,555.50 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,119 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,152 | $45.55 | $143,573.60 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,219 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,235 | $45.54 | $101,781.90 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,371 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,287 | $45.45 | $285,736.61 |
DisclosureSEC source: 0001179110-11-002412 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2010 Filed Apr 16, 2010 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,499 | $52.36 | $183,207.64 |
DisclosureSEC source: 0001179110-10-007071 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,319 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.40 | $10,879.00 |
DisclosureSEC source: 0001179110-10-004239 · edgar.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,818 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $54.39 | $48,951.00 |
DisclosureSEC source: 0001179110-10-004239 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,018 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,141 | $54.38 | $551,467.58 |
DisclosureSEC source: 0001179110-10-004239 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,918 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,326 | $54.12 | $396,483.12 |
DisclosureSEC source: 0001179110-10-004239 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,059 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value · Derivative | 34,600 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003600 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,600 Underlying: Common Shares · 34,600 shares Expires 2020-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,534 on 2/19/2011, 11,533 on 2/19/2012, and 11,533 on 2/19/2013. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003600 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,385 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 23,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003600 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,385 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $54.41 | $65,294.40 |
DisclosureSEC source: 0001179110-10-003165 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,785 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,231 | $54.41 | $339,034.94 |
DisclosureSEC source: 0001179110-10-003165 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,985 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,569 | $53.93 | $246,406.17 |
DisclosureSEC source: 0001179110-10-003165 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,216 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 9,875 | $0.00 Strike: $52.75 | $0.00 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · derivative · entry 9 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,875 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,175 | $54.01 | $495,550.93 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 7 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,785 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $54.01 | $16,203.60 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,960 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.01 | $5,401.07 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,260 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.01 | $5,401.05 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,360 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.01 | $5,401.09 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,460 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.01 | $5,401.15 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,560 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 9,875 | $52.75 | $520,906.25 |
DisclosureSEC source: 0001179110-09-016822 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2009 Filed Dec 31, 2009 22:03 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 9,875 | $0.00 Strike: $52.75 | $0.00 |
DisclosureSEC source: 0001179110-09-017636 · edgar.xml · derivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,875 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F2 · shares: The Form 4 filed on December 11, 2009 inadvertently reported that the exercised options were acquired, rather than disposed of, by the reporting person. Read SEC document |
| October 26, 2009 Filed Oct 28, 2009 21:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,416 | $0.00 Strike: $51.31 | $0.00 |
DisclosureSEC source: 0001179110-09-014816 · edgar.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416 Underlying: Common Shares · 1,416 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 26, 2009 Filed Oct 28, 2009 21:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,594 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001179110-09-014816 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,594 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 26, 2009 Filed Oct 28, 2009 21:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,416 | $51.31 | $72,654.96 |
DisclosureSEC source: 0001179110-09-014816 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,785 Read SEC document |
| October 26, 2009 Filed Oct 28, 2009 21:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,594 | $41.03 | $65,404.53 |
DisclosureSEC source: 0001179110-09-014816 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2009 Filed Oct 20, 2009 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 9,932 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001179110-09-014652 · edgar.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,932 Underlying: Common shares · 9,932 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 16, 2009 Filed Oct 20, 2009 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 11,244 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001179110-09-014652 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594 Underlying: Common shares · 11,244 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 16, 2009 Filed Oct 20, 2009 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,932 | $51.91 | $515,570.12 |
DisclosureSEC source: 0001179110-09-014652 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,607 Read SEC document |
| October 16, 2009 Filed Oct 20, 2009 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,244 | $41.03 | $461,360.43 |
DisclosureSEC source: 0001179110-09-014652 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2009 Filed Oct 1, 2009 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,290 | $0.00 Strike: $48.10 | $0.00 |
DisclosureSEC source: 0001179110-09-013931 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,290 shares Expires 2009-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 29, 2009 Filed Oct 1, 2009 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,290 | $48.85 | $209,566.50 |
DisclosureSEC source: 0001179110-09-013931 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,295 Read SEC document |
| September 29, 2009 Filed Oct 1, 2009 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,290 | $48.10 | $206,349.00 |
DisclosureSEC source: 0001179110-09-013931 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2009 Filed Sep 1, 2009 21:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 460 | $0.00 Strike: $46.61 | $0.00 |
DisclosureSEC source: 0001179110-09-012741 · edgar.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460 Underlying: Common shares · 460 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 28, 2009 Filed Sep 1, 2009 21:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 548 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001179110-09-012741 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 548 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 28, 2009 Filed Sep 1, 2009 21:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 460 | $46.61 | $21,440.60 |
DisclosureSEC source: 0001179110-09-012741 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,593 Read SEC document |
| August 28, 2009 Filed Sep 1, 2009 21:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 548 | $33.23 | $18,210.81 |
DisclosureSEC source: 0001179110-09-012741 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2009 Filed Aug 26, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,324 | $0.00 Strike: $45.39 | $0.00 |
DisclosureSEC source: 0001179110-09-012589 · edgar.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,324 Underlying: Common shares · 2,324 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2009 Filed Aug 26, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,082 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001179110-09-012589 · edgar.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548 Underlying: Common shares · 3,082 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.